Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia

A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788

NCT04132050 ·Status: COMPLETED ·Phase: PHASE3

The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia

NCT01667263 ·Status: COMPLETED ·Phase: PHASE2

TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years

NCT04890041 ·Status: RECRUITING ·Phase: NA

The Study of Different Dose Rituximab in the Treatment of ITP

NCT03258866 ·Status: COMPLETED ·Phase: PHASE4

rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP

NCT01525836 ·Status: COMPLETED ·Phase: PHASE3

Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)

NCT06168851 ·Status: RECRUITING ·Phase: PHASE2

Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia

NCT01317966 ·Status: WITHDRAWN

All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

NCT01882127 ·Status: WITHDRAWN ·Phase: PHASE3

The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

NCT04217148 ·Status: COMPLETED ·Phase: PHASE2

Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura

NCT06137105 ·Status: NOT_YET_RECRUITING

National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients

NCT07268898 ·Status: NOT_YET_RECRUITING

Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia

NCT06281327 ·Status: RECRUITING ·Phase: PHASE2

Atorvastatin in Management of Newly Diagnosed ITP

NCT03692754 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

NCT01719692 ·Status: COMPLETED ·Phase: NA

Treatment of ITP With Rituximab and / or Accutane

NCT02757196 ·Status: UNKNOWN ·Phase: PHASE2

A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone

NCT00161564 ·Status: WITHDRAWN ·Phase: PHASE2

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

NCT06478537 ·Status: RECRUITING ·Phase: PHASE2

Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura

NCT00486421 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Anti-BCMA CAR T-Cell Therapy for R/R ITP

NCT05315778 ·Status: UNKNOWN ·Phase: PHASE2

The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9

NCT05438875 ·Status: COMPLETED ·Phase: PHASE3

A Study of Switching Avatrombopag and Rh-TPO in ITP

NCT04913597 ·Status: UNKNOWN

TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

NCT04915482 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003

NCT00625443 ·Status: COMPLETED ·Phase: PHASE2

Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness

NCT06254560 ·Status: RECRUITING ·Phase: PHASE2

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

NCT06287567 ·Status: COMPLETED ·Phase: PHASE2